These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 2297699

  • 1. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH, Billings PC, Carew JA, Keller-McGandy C, Newberne P, Kennedy AR.
    Cancer Res; 1990 Feb 01; 50(3):580-6. PubMed ID: 2297699
    [Abstract] [Full Text] [Related]

  • 2. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.
    Kennedy AR, Billings PC, Wan XS, Newberne PM.
    Nutr Cancer; 2002 Feb 01; 43(2):174-86. PubMed ID: 12588698
    [Abstract] [Full Text] [Related]

  • 3. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002 Feb 01; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevention of carcinogenesis by protease inhibitors.
    Kennedy AR.
    Cancer Res; 1994 Apr 01; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
    [Abstract] [Full Text] [Related]

  • 6. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
    Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM.
    Cancer Res; 1996 Feb 15; 56(4):679-82. PubMed ID: 8630994
    [Abstract] [Full Text] [Related]

  • 7. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW, Huang SC, Lin-Shiau SY, Lin JK.
    Carcinogenesis; 2005 Jul 15; 26(7):1296-306. PubMed ID: 15746161
    [Abstract] [Full Text] [Related]

  • 8. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H, Kennedy AR, Witschi H, Shen WC.
    J Drug Target; 1993 Jul 15; 1(1):41-9. PubMed ID: 8069543
    [Abstract] [Full Text] [Related]

  • 9. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans.
    Evans SM, Van Winkle T, Szuhaj B, Michel KE, Kennedy AR.
    Radiat Res; 1992 Nov 15; 132(2):259-62. PubMed ID: 1438709
    [Abstract] [Full Text] [Related]

  • 10. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR.
    Nutr Cancer; 1999 Nov 15; 33(2):165-73. PubMed ID: 10368812
    [Abstract] [Full Text] [Related]

  • 11. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 15; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 12. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC, St Clair W, Owen AJ, Kennedy AR.
    Cancer Res; 1988 Apr 01; 48(7):1798-802. PubMed ID: 3280120
    [Abstract] [Full Text] [Related]

  • 13. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.
    Suzuki K, Yano T, Sadzuka Y, Sugiyama T, Seki T, Asano R.
    Oncol Rep; 2005 Jun 01; 13(6):1247-50. PubMed ID: 15870950
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of oral carcinogenesis by a protease inhibitor.
    Messadi DV, Billings P, Shklar G, Kennedy AR.
    J Natl Cancer Inst; 1986 Mar 01; 76(3):447-52. PubMed ID: 3081747
    [Abstract] [Full Text] [Related]

  • 15. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM.
    Neurourol Urodyn; 2003 Mar 01; 22(1):54-7. PubMed ID: 12478602
    [Abstract] [Full Text] [Related]

  • 16. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 01; 9(1):43-7. PubMed ID: 10667462
    [Abstract] [Full Text] [Related]

  • 17. Selective radioprotection of normal tissues by Bowman-birk proteinase inhibitor (BBI) in mice.
    Dittmann K, Toulany M, Classen J, Heinrich V, Milas L, Rodemann HP.
    Strahlenther Onkol; 2005 Mar 01; 181(3):191-6. PubMed ID: 15756524
    [Abstract] [Full Text] [Related]

  • 18. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
    Ware JH, Wan XS, Kennedy AR.
    Nutr Cancer; 1999 Mar 01; 33(2):174-7. PubMed ID: 10368813
    [Abstract] [Full Text] [Related]

  • 19. Tumor induction in mice administered neonatally with 1,2-dimethylhydrazine.
    Fujii K, Komano H.
    Sci Rep Res Inst Tohoku Univ Med; 1989 Dec 01; 36(1-4):46-50. PubMed ID: 2640067
    [Abstract] [Full Text] [Related]

  • 20. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA, Paterson Y, Kennedy AR.
    Nutr Cancer; 1994 Dec 01; 22(2):185-93. PubMed ID: 14502847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.